NCT06269354

Brief Summary

The clinical diagnosis and treatment of lower limb bone defect is a difficult problem in orthopedics. The traditional treatment has the shortcomings of long treatment period, no weight bearing in the early stage of the limb, weak mechanical strength, many complications, and difficulty in repairing deformed and large segment bone defects around the joint. The Orthopedics Department of Peking University Third Hospital, the lead unit of this study, developed the TCBridge system based on three-dimensional (3D) printing technology in the early stage, which is the first approved 3D printing lower limb long bone defect repair system in China. The system can achieve personalized and accurate repair of lower limb bone defects, and ensure patients to carry out limb weight and functional exercise safely in the early stage after surgery. On this basis, this study will establish a multi-center clinical case cohort to achieve accurate comprehensive diagnosis and treatment of lower limb bone defects, benefiting patients and contributing to society.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Nov 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Nov 2023Dec 2026

Study Start

First participant enrolled

November 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 21, 2024

Status Verified

November 1, 2023

Enrollment Period

2.6 years

First QC Date

December 18, 2023

Last Update Submit

February 20, 2024

Conditions

Keywords

3D printing technology; bone defects; clinical effects

Outcome Measures

Primary Outcomes (2)

  • Evaluation of implant stability, new bone growth- limb length

    X-ray X、CT images

    post-operative 1.3.6.12.24.36 months

  • Evaluation of bone healing

    computed tomography (CT)

    post-operative 3.6.12.24.36 months

Secondary Outcomes (5)

  • Pain assessment

    post-operative 1.3.6.12.24.36 months

  • Evaluation of life quality and health status.

    post-operative 1.3.6.12.24.36 months

  • Evaluation of knee function

    post-operative 1.3.6.12.24.36 months

  • Evaluation of hip function

    post-operative 1.3.6.12.24.36 months

  • Evaluation of ankle function

    post-operative 1.3.6.12.24.36 months

Study Arms (3)

Traumatic bone defect in lower limb

Traumatic bone defect in lower limb

Device: 3D printed prostheses

Infective lower limb bone defect

Infective lower limb bone defect

Device: 3D printed prostheses

Neoplastic bone defect in lower limb

Neoplastic bone defect in lower limb

Device: 3D printed prostheses

Interventions

3D printed prostheses

Infective lower limb bone defectNeoplastic bone defect in lower limbTraumatic bone defect in lower limb

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with lower limb defects

You may qualify if:

  • Patients with traumatic lower limb bone defect;
  • Infected lower limb bone defect patients;
  • Patients with neoplastic lower limb bone defect;
  • The above reasons caused bone defects of more than 5CM
  • at least 18 years of age;
  • Sign an informed agreement and join the study cohort voluntarily.

You may not qualify if:

  • Patients who do not agree to the use of 3D printed microporous titanium alloy prostheses;
  • Patients who cannot tolerate surgery;
  • the subjects cannot comply with the follow-up or affect the scientific and integrity of the study;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, Haidian, China

RECRUITING

Central Study Contacts

Bingchuan Liu, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2023

First Posted

February 21, 2024

Study Start

November 1, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 21, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations